Literature DB >> 2882276

HIV-2 (West Germany, 1984)

A Werner, S Staszewski, E B Helm, W Stille, K Weber, R Kurth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2882276     DOI： 10.1016/s0140-6736(87)91655-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  No evidence of HIV-2 infection in subjects at risk for AIDS living in north-east Italy.

Authors:  A Del Mistro; A De Rossi; E Francavilla; M T Sartori; L Chieco-Bianchi
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

2.  Comparative evaluation of 36 commercial assays for detecting antibodies to HIV.

Authors:  I Van Kerckhoven; G Vercauteren; P Piot; G van der Groen
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

Review 3.  Blotting techniques for the study of DNA, RNA, and proteins.

Authors:  P C Hayes; C R Wolf; J D Hayes
Journal:  BMJ       Date:  1989-10-14

4.  HIV-II infection with initial neurological manifestation.

Authors:  E Klemm; K E Schneweis; R Horn; W Tackmann; G Schulze; J Schneider
Journal:  J Neurol       Date:  1988-05       Impact factor: 4.849

5.  Isolation of human immunodeficiency virus type 2 from a homosexual man in Belgium.

Authors:  B Vanderborght; R J De Leys; P Nijs; G Van der Groen; J Merregaert; H Prinsen; H Van Heuverswyn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

6.  Evaluation of a line immunoassay for simultaneous confirmation of antibodies to HIV-1 and HIV-2.

Authors:  K Fransen; D E Pollet; M Peeters; I van Kerckhoven; G Beelaert; G Vercauteren; P Piot; G van der Groen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

7.  Diagnosis of human immunodeficiency virus (HIV) infection: multicenter evaluation of a newly developed anti-HIV 1 and 2 enzyme immunoassay.

Authors:  G Hess; F Avillez; M H Lourenco; F D'Agostino; G Cambie; P Piot; G Vercauteren; U Michl; W Melchior; H Bayer
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.